ANIP - Slight Up ChannelA slight up channel has appeared in the larger overarching down channel.
If this channel takes dominance we could see a price rise.
This price rise is plotted with the bars pattern tool.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.24 USD
18.78 M USD
486.82 M USD
17.41 M
About ANI Pharmaceuticals, Inc.
Sector
Industry
CEO
Nikhil Lalwani
Website
Headquarters
Baudette
Founded
1996
FIGI
BBG000KK1L04
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Is ready for 77?I think is ready to liftoff with positive divergence but there is a possibility of another drop on the green line.
Bye, Bye, mANIPulationSold 750 shares of ANIP
$22,329 back into my Account.
We will see where it closes the day (?)
But, I would rather have the Money!
mANIPulation"They" put me thru a lot of Angst!
But, I collected 750 shares of: ANIP .
$27.85 = Profitable.
ANIP 4daily 150% gains(STOCKS)before we kick start the update. your upvotes/subs are appreciated.
Why get subbed to to me on Tradingview?
-15+ years real live trading experience
-TOP Author on TradingView
-professional chart break downs
-key levels
-no junk on my charts
-frequent updates
-covering FX/crypto/US stocks
-24/7
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate ANIP: ANI Pharmaceuticals, Inc.
2020-01-16 08:30:00
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
ANIP reviewThis is a review of my previous chart setup. Basically a break even trade. I wouldn’t hold on to this stock anymore but you can if you think otherwise. That’s it
ANIP Triangle formation Two consecutive green candles that closed higher than the last. That’s why I’m going long on this one
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ANIP is 61.05 USD — it has decreased by −0.03% in the past 24 hours. Watch ANI Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ANI Pharmaceuticals, Inc. stocks are traded under the ticker ANIP.
ANIP stock has risen by 0.38% compared to the previous week, the month change is a 4.14% rise, over the last year ANI Pharmaceuticals, Inc. has showed a 11.06% increase.
We've gathered analysts' opinions on ANI Pharmaceuticals, Inc. future price: according to them, ANIP price has a max estimate of 94.00 USD and a min estimate of 62.00 USD. Watch ANIP chart and read a more detailed ANI Pharmaceuticals, Inc. stock forecast: see what analysts think of ANI Pharmaceuticals, Inc. and suggest that you do with its stocks.
ANIP reached its all-time high on Nov 29, 2004 with the price of 392.04 USD, and its all-time low was 4.80 USD and was reached on Jun 26, 2013. View more price dynamics on ANIP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ANIP stock is 7.27% volatile and has beta coefficient of 0.30. Track ANI Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is ANI Pharmaceuticals, Inc. there?
Today ANI Pharmaceuticals, Inc. has the market capitalization of 1.23 B, it has decreased by −1.30% over the last week.
Yes, you can track ANI Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ANI Pharmaceuticals, Inc. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ANIP earnings for the last quarter are 1.34 USD per share, whereas the estimation was 1.09 USD resulting in a 23.39% surprise. The estimated earnings for the next quarter are 1.41 USD per share. See more details about ANI Pharmaceuticals, Inc. earnings.
ANI Pharmaceuticals, Inc. revenue for the last quarter amounts to 148.33 M USD, despite the estimated figure of 144.37 M USD. In the next quarter, revenue is expected to reach 170.51 M USD.
ANIP net income for the last quarter is −2.29 M USD, while the quarter before that showed 16.40 M USD of net income which accounts for −113.94% change. Track more ANI Pharmaceuticals, Inc. financial stats to get the full picture.
No, ANIP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 642.00 employees. See our rating of the largest employees — is ANI Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANI Pharmaceuticals, Inc. EBITDA is 105.30 M USD, and current EBITDA margin is 22.46%. See more stats in ANI Pharmaceuticals, Inc. financial statements.
Like other stocks, ANIP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANI Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANI Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANI Pharmaceuticals, Inc. stock shows the buy signal. See more of ANI Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.